| 标题 |
Postprogression Outcomes for Osimertinib versus Standard-of-Care EGFR-TKI in Patients with Previously Untreated EGFR-mutated Advanced Non–Small Cell Lung Cancer |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical Cancer Research 作者:David Planchard; Michael J. Boyer; Jong-Seok Lee; Arunee Dechaphunkul; Parneet K. Cheema; et al 出版日期:2019-01-19 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)